Patients with vitiligo who received long-term NBUVB phototherapy vs no phototherapy were associated with reduced risks for cardiometabolic diseases.

Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...

Recent network meta-analyses identified the relative outcomes of various vitiligo monotherapies on vitiligo at 6 months.

Phototherapy treatments include narrowband UV-B (NBUVB) and psoralen and UVA (PUVA). NBUVB is indicated for generalized nonsegmental vitiligo, with total body treatments being suggested for ...

Vitiligo is believed to be an autoimmune condition ... progression of active vitiligo and restore your natural skin color. Phototherapy is a type of light therapy that uses narrow-band ultraviolet ...

John Kenney Jr., MD, Lifetime Achievement Award and Lectureship recipient Pearl E. Grimes, MD, FAAD, delivered a tribute to her predecessor as she discussed the history and advancements of vitiligo.

An ongoing global phase III trial (CUV105) is evaluating the safety and efficacy of SCENESSE® as an adjunct to narrowband ultraviolet B phototherapy in vitiligo patients aged 12 years old and ...

A dermatologist told her she had vitiligo. Two years later she discontinued her medication after trying other forms of treatment like phototherapy. “I stopped the treatment and learnt to live ...